Publications - Oncology Translational Research Laboratory

Uray, I., Dmitrovsky, E., Brown, P.: Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic.
Semin. Oncol. 43 (1), 49-64, 2016.

Chowdhury, P., Powell, R., Stephan, C., Uray, I., Talley, T., Karki, M., Tripathi, D., Park, Y., Mancini, M., Davies, P., Dere, R.: Bexarotene: a Novel Modulator of AURKA and the Primary Cilium in VHL-deficient Cells.
J. Cell Sci. 131 1-12, 2018.

Uray, I., Uray, K.: Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface.
Int. J. Mol. Sci. 22 (21), 1-23, 2021.

Jdeed, S., Erdős, E., Bálint, B., Uray, I.: The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling.
Mol. Cancer Res. 20 (7), 1071-1082, 2022.

Jdeed, S., Lengyel, M., Uray, I.: Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-[béta] Signaling.
Cells. 11 (17), 1-15, 2022.

Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Cell Death Dis. 14 (3), 1-10, 2023.

Lengyel M., Molnár Á., Nagy T., Jdeed S., Garai I., Horváth Zs.,  Uray, I.: Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.
Matrix Biology. (in review)

Last update: 2024. 04. 12. 13:51